- 4th Floor, Royal Arcade Raghunathpur, Nandankanan Road, Bhubaneswar, 751024
- +91 89174 20936
- contact@drrajeebjena.com
Pregnancy screening tests in Bhubaneswar help assess maternal health, fetal development and pregnancy-related risks at different stages of pregnancy. Depending on gestational age and individual risk factors, screening and monitoring may include first-trimester screening, aneuploidy risk assessment, pre-eclampsia screening, fetal growth surveillance, Doppler studies, NST and CTG.
Dr. Rajeeb Jena provides fetal medicine and high-risk pregnancy care, including advanced pregnancy ultrasound, fetal imaging, fetal testing, pregnancy screening and ongoing fetal surveillance. Each pregnancy is assessed individually based on maternal health, gestational age, previous pregnancy history and clinical findings.
For expectant mothers looking for prenatal screening in Bhubaneswar, pregnancy screening Kalarahanga, or pregnancy monitoring around Raghunathpur and Nandankanan Road, the appropriate tests are selected according to the needs of the pregnancy.
Pregnancy screening and monitoring involve different assessments performed during pregnancy to understand maternal and fetal health.
Some tests estimate the likelihood of a condition, while others monitor an already identified concern. A screening result does not always provide a definite diagnosis, and an abnormal result may require further evaluation.
Pregnancy monitoring may include:
The timing and frequency depend on gestational age, maternal health, previous pregnancy history and other clinical factors.
The first trimester is an important period for assessing early fetal development and estimating the likelihood of certain chromosomal conditions.
Combined first trimester screening in Bhubaneswar may use a combination of maternal information, ultrasound measurements and blood markers, depending on the screening protocol.
Combined first trimester screening may involve:
Maternal blood-marker assessment may include markers such as PAPP-A and free beta hCG depending on the screening protocol being used.
The result provides a risk estimate, rather than confirming whether a chromosomal condition is present.
First-trimester screening is performed during an appropriate gestational window. Patients may therefore search for combined screening at 12 weeks, first trimester screening Bhubaneswar, or a double marker test Bhubaneswar.
The exact timing and combination of tests should be determined by the healthcare provider based on gestational age and the clinical situation.
A double marker test in pregnancy is a maternal blood-marker screening test that may be incorporated into first-trimester chromosomal risk assessment.
It is a screening test, not a diagnostic test. The result is interpreted together with relevant clinical and ultrasound information rather than as an isolated number.
A higher-risk result does not automatically mean that the baby has a chromosomal condition, while a lower-risk result cannot completely exclude every possible condition.
The double marker test at 12 weeks may be part of first-trimester screening when performed within the appropriate gestational window.
There is no single “normal value” that should be interpreted without context. Screening results are used to estimate risk, and your doctor can explain what your particular result means.
Aneuploidy risk assessment in Bhubaneswar evaluates the likelihood of certain chromosomal differences, including:
Depending on the pregnancy, risk assessment may involve ultrasound findings, maternal blood tests, non-invasive prenatal testing or other investigations.
Chromosomal screening combines relevant maternal, ultrasound and/or blood-test information to estimate the likelihood of a condition.
The result is expressed as a risk estimate, not a confirmed diagnosis. Further evaluation may be discussed when screening indicates an increased risk.
A low-risk screening result reduces the estimated likelihood of the condition being screened for but does not eliminate every possibility.
A high-risk screening result also does not mean that the baby definitely has the condition. Further screening or diagnostic testing may be considered depending on the individual circumstances.
This distinction is important for patients searching for screening for Down syndrome in Bhubaneswar or an aneuploidy risk assessment specialist in Bhubaneswar.
Pre-eclampsia screening in Bhubaneswar may help identify women who have an increased risk of developing pre-eclampsia during pregnancy.
Risk assessment may consider:
Women identified as having increased risk may require closer monitoring during pregnancy.
Pre-eclampsia screening in the first trimester can form part of early pregnancy risk assessment when clinically appropriate.
Depending on the screening approach, additional measurements may be considered. The purpose is to estimate risk and help guide pregnancy monitoring rather than to predict with certainty whether pre-eclampsia will develop.
A higher estimated risk may lead to closer follow-up during pregnancy. The appropriate monitoring plan depends on the woman’s individual risk factors and clinical assessment.
Questions about preventive treatment, including whether aspirin for pre-eclampsia prevention is appropriate, should be discussed directly with the treating healthcare professional rather than started without medical advice.
Fetal growth surveillance in Bhubaneswar is used to monitor how the baby is developing, particularly when there are concerns about fetal growth or placental function.
Fetal growth monitoring may include serial ultrasound examinations assessing:
A single measurement may not provide the complete picture. Serial assessments help healthcare professionals evaluate the pattern of growth over time.
Closer fetal growth surveillance may be considered when there are concerns such as:
The frequency of growth scans depends on the individual pregnancy and the reason for monitoring.
Growth assessment may be combined with Doppler studies when clinically indicated.
Doppler can provide information about blood flow, while ultrasound assesses fetal growth, amniotic fluid and other relevant findings.
The placenta plays an important role in providing oxygen and nutrients to the developing baby.
Placental assessment may be important when there are concerns about:
When a placental disorder is suspected or identified, the type and frequency of monitoring may be adjusted according to the clinical situation.
As pregnancy progresses, some pregnancies require closer assessment of fetal well-being.
Depending on the clinical situation, monitoring may include:
The purpose is to understand how the baby is doing and determine whether additional surveillance or changes to the pregnancy care plan may be appropriate.
An NST (Non-Stress Test) is a form of fetal heart-rate monitoring used in selected pregnancies to assess fetal well-being.
Patients may be advised to undergo an NST test in pregnancy in Bhubaneswar when there are specific clinical indications, particularly later in pregnancy.
An NST may be considered when there are concerns such as:
NST is not automatically required for every pregnancy. The healthcare provider decides whether it is appropriate based on the overall clinical picture.
An NST result is interpreted according to the fetal heart-rate pattern and the clinical context.
A result should not be interpreted in isolation. Your healthcare provider considers gestational age, fetal movements, maternal health and other pregnancy findings when assessing fetal well-being.
CTG (Cardiotocography) records the baby’s heart rate together with uterine activity over a period of time.
CTG in pregnancy in Bhubaneswar may be recommended when additional fetal monitoring is clinically indicated, particularly later in pregnancy.
CTG can provide information about:
CTG may be considered when there are concerns such as reduced fetal movement, high-risk pregnancy, fetal growth concerns or other situations requiring closer surveillance.
A CTG should be interpreted by a qualified healthcare professional in the context of the entire pregnancy.
The meaning of a CTG tracing depends on the clinical circumstances, gestational age and other maternal and fetal findings. A tracing should therefore not be judged using one isolated feature or number.
NST and CTG are both methods of monitoring fetal heart rate, but CTG additionally records uterine activity.
NST | CTG |
Non-Stress Test | Cardiotocography |
Monitors fetal heart rate | Records fetal heart rate and uterine activity |
Used to assess fetal well-being | Used for fetal and uterine monitoring |
Recommended when clinically indicated | Recommended when clinically indicated |
Your healthcare provider will determine which type of monitoring is appropriate for your pregnancy.
Some pregnancies require more detailed or frequent monitoring because of maternal health conditions, previous pregnancy complications or concerns identified during the current pregnancy.
High-risk pregnancy monitoring may be considered in situations including:
The monitoring plan is individualised according to maternal health and fetal development.
Ultrasound is an important component of pregnancy screening and monitoring. Different scans provide different information depending on gestational age and the clinical question being addressed.
Advanced fetal imaging may include:
Additional imaging may be recommended when a routine scan identifies a finding that needs closer assessment.
A specialist pregnancy screening consultation may be appropriate if:
A specialist consultation can help determine which tests are appropriate and when they should be performed.
The information on this page is intended for general educational purposes and does not replace professional medical consultation, diagnosis or treatment.
Pregnancy screening results and monitoring requirements can vary significantly between individuals. Screening tests have limitations and may sometimes require additional evaluation. Always discuss your pregnancy, test results and recommended monitoring with a qualified healthcare professional who can assess your individual circumstances.
A double marker test is a maternal blood-marker screening assessment that may be used as part of first-trimester chromosomal risk assessment. It is performed within the appropriate gestational window and is interpreted alongside relevant clinical and ultrasound information.
A high-risk screening result does not automatically mean that the baby has the condition being screened for. Screening estimates likelihood rather than providing a definite diagnosis, and your healthcare provider may discuss further screening or diagnostic options based on the individual circumstances.
No. A low-risk result reduces the estimated likelihood but cannot completely eliminate every possibility. Screening tests have limitations and should be understood as risk assessment rather than definitive diagnosis.
Pre-eclampsia risk assessment may be considered during pregnancy based on maternal characteristics, medical history, blood pressure and other relevant clinical or ultrasound-related measurements. Women identified as having increased risk may require closer monitoring.
NST may be recommended when there are specific clinical concerns, such as reduced fetal movement, high-risk pregnancy, certain maternal medical conditions, fetal growth concerns, pregnancy continuing beyond the expected period or concerns about fetal well-being. It is not automatically required for every pregnancy.
CTG is a form of fetal heart-rate monitoring that records the baby’s heart rate together with uterine activity over a period of time. The duration and need for CTG depend on the clinical situation, and the test should be performed and interpreted by the appropriate healthcare professional.
